Ces radiol. 2010, 64(1):11-19

Contribution of the contrast enhanced ultrasound in the differential diagnosis of the focal liver lesionsOriginal article

Šárka Bohatá1, Tomáš Pavlík2, Danuše Chlumská1, Vlastimil Válek1
1 Radiologická klinika FN, Brno
2 Institut biostatistiky a analýz MU, Brno

Aim: Co compare retrospectively study of different imaging modalities (CEUS, CT, MR) and to determine the hit rate of these modalities with regard to histological diagnose and with respect to distinguish between benign and malignant lesion in general, the proposal of optimal diagnostic algorithm of focal liver lesions.

Method: Retrospective evaluation of th group of 62 patients examined from 2005 to 2009 with histological evaluation. US examinations were done on ATL HDI 5000 and IU 22 Phillips. CT examinations on Siemens Somatom plus or Phillips Brilliance (64), using dynamic postcontrast examination. MR on Phillips Achieva 1.5 T, using hepatospecific contrast agents and dynamic postcontrast examination in 4 phases.
Beyond the hit rate of the modalities with regard to histological diagnose also the sensitivity, specificity, positive predictive values and negative predictive values to distiguish malignant lesion from benign were evaluated.

Results: Concerning the histological diagnose, MR has the hit rate of 85.7%, CEUS - 82%, CT - 62%. For differentiation between malignant and benign lesion MR sensitivity was 93,8% and specificity 100%, CEUS 91.4% and 92.3% , CT 77.8% and 88.5%. PPV were 100%, 94% and 90% and NPV 92%, 90% and 74% for MR, CEUS and CT respectively.

Conclusion: Our sensitivity, specificity, PPV, NPV and hit rates well correlate with those described in literature, confiming that CEUS is meaningful diagnostic tool in the diagnostic algortithm of focal liver lesions.

Keywords: diagnosis, differential, liver, microbubbles, ultrasonography

Accepted: August 15, 2009; Published: March 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bohatá Š, Pavlík T, Chlumská D, Válek V. Contribution of the contrast enhanced ultrasound in the differential diagnosis of the focal liver lesions. Ces radiol. 2010;64(1):11-19.
Download citation

References

  1. Lencioni R, et al. Enhancing the role of ultrasound with contrast agents, 1st ed. Pisa, Italy: Springer 2006; 252 s. Go to original source...
  2. Averkiou M, Powers J. Ultrasound contrast media in the characterisation of soft tissue lesions: ongoing research. MedicaMundi 2007; 51(2,3): 11.
  3. Solbiati L, Martegani A, Leen E, et al. Contrast-enhanced ultrasound of liver diseases, 1st ed. Milano, Italy: Springer 2003. Go to original source...
  4. Schneider G, Grazioli L, Saini S. MRI of the liver, 2nd edition. Milano, Italy: Springer 2006; 412 s. Go to original source...
  5. Strobel D, Seitz K, Blank W, et al. Contrast-enhanced ultrasound for the characterization of focal liver lesions - diagnostic accuracy in clinical practice[1] (DEGUM multicenter trial), Ultraschall in Med 2008; 29: 499-505, DOI: 10.1055/s-2008-1027806 Go to original source... Go to PubMed...
  6. Averkiou MA, Roundhill DN, Powers JE. New imaging technique based on the nonlinear properties of tissues. Proceedings of hte IEEE ultrasonic Symposium 1997; 2: 1561-1566. Go to original source...
  7. Burns PN, Wilson SR, Simpson WH. Pulse inversion imaging of liver blood flow: Improved method for characterizing focal masses with microbubble contrast. Invest Radiol 2000; 35(1): 58-71. Go to original source... Go to PubMed...
  8. Catalano O, Nunziata A, Lobianco R, Siani A. Real-time harmonic contrast materiál specific US of focal liver lesions. Radiographics 2005; 25: 333-349. Go to original source... Go to PubMed...
  9. Kim TK, Choi BI, Han JK, et al. Hepatic tumors: contrast agent enhancement patterns with pulse - inversion harmonic US. Radiology 2000; 216: 411-417. Go to original source... Go to PubMed...
  10. Quaia E, Calliada F, Bertolotto M, et al. Characterization of focal liver lesions with contrastspecific US modes and a sulfur hexafluoride-filled microbubble contrast agent: Diagnostic performance and confidence. Radiology 2004; 232: 420-430. Go to original source... Go to PubMed...
  11. Brannigan M, Burns PN, Wilson SR. Blood flow patterns in focal liver lesions at microbubble-enhanced US. RadioGraphics 2004; 24: 921-935. Go to original source... Go to PubMed...
  12. Stieger S, Caskey Ch, Adamson R, et al. Enhancement of vascular permeability with low-frequency contrast-enhanced ultrasound in the chorioallantoic membrane model. Radiology 2007; 243: 112-121. Go to original source... Go to PubMed...
  13. Oliver JH, Baron RL. Helical biphasic contrast-enhanced CT of the Liver: techniwue, indications, interpretation and pitfalls. Radiology 1996, 201; 1-14. Go to original source... Go to PubMed...
  14. Válek V, Kala Z, Kiss I, et al. Maligní ložiskové procesy jater. Diagnostika a léčba včetně minimálně invazivních metod, 1. vydání. Praha: Grada Publishing 2006; 416 s.
  15. Weis J, Bořuta P. Úvod do magnetické rezonancie. Bratislava: Datex 1998.
  16. Reimer P, Parizel PM, Stichnoth FA. Clinical MR imaging. A practical approach, 2nd edition. Heidelberg, Germany: Springer 2003; 1-65, 271-273.
  17. Leen E, Ceccotti P, Kalogeropoulou Ch, et al. Prospective multicenter trial evaluating a novel method of characterizing focal liver lesions using contrast-enhanced sonography; AJR 2006; 186: 1551-1559. Go to original source... Go to PubMed...
  18. Soye JA, Mullan CP, Porter S, et al. The use of contrast-enhanced ultrasound in the characterisation of focal liver lesions. Ulster Med J 2007; 76(1): 22-25.
  19. Isozaki T, Nemata K, Kiba T, et al. Differential diagnosis of hepatic tumors by using contrast enhancement patterns at US. Radiology 2003; 229: 798-805. Go to original source... Go to PubMed...
  20. Dietrich CF, Kratzer W, Strobe D, et al. Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI. World J Gastroenterol 2006; 12(11): 1699-1705. Go to original source... Go to PubMed...
  21. Albrecht T, Hoffmann CW, Schmitz SA, et al. Phase inversion sonography during the liver specific late phase of contrast enhancement: improved detection of liver metastases. AJR 2001; 176: 1191-1198. Go to original source... Go to PubMed...
  22. Mechl M, Válek V, Bruel P, et al. Characterisation of the solid liver lesions by CEUS-multicenter international study. Czech Radiology 2007; 60; 5: 387.
  23. Trillaud H, Bruel JM, Valette PJ, et al. Characterization of focal liver lesions with SonoVue®-enhanced sonography: International multicenter-study incomparison to CT and MRI. World J Gastroenterol 2009; 15(30): 3748-3756. Go to original source... Go to PubMed...
  24. Albrecht T, Blomley MKJ, Burns PN, et al. Improved detection of hepatic metastases with pulse inversion ultrasonography during the liver specific phase of SHU 508A (Levovist) - a multi-centre study. Radiology 2002; 227: 361-370. Go to original source... Go to PubMed...
  25. Jones EC, Chezmar JL, Nelson RC, Bernardino ME.The frequency and significance of small (less than or equal 15 mm) hepatic lesions detected by CT. AJR 1992; 158: 535-539. Go to original source... Go to PubMed...
  26. Leifer D, Middleton W. Teefey S, et al. Follow-up of patiens at low risk for hepatic malignancy with a characteristic haemangioma at US. Radiology 2000; 214: 167-172. Go to original source... Go to PubMed...
  27. Schwarz LH, Gandras EJ, Colangelo SM, Ercolani MC, Panicek DM. Prevalence and importace of small hepatic lesions found at CT in patients with cancer. Radiology 1999; 210: 71-74. Go to original source... Go to PubMed...
  28. Caturelli E, Pompili M, Bartolucci F, et al. Hemangioma-like lesions in chronic liver disease: diagnostic evaluation in patiens. Radiology 2001; 220: 337-342. Go to original source... Go to PubMed...
  29. Shimizu A, Ito K, Koike S, et al. Cirrhosis or chronic hepatitis: evaluation of small (2 cm) early-enhancing hepatic lesions with serial contrast-enhanced dynamic MR imaging. Radiology 2003; 226: 550-555. Go to original source... Go to PubMed...
  30. Kolombo M, De Frachis R, Del Ninno E, et al. Hepatocellular carcinoma in italian patiens with cirrhosis; Lancet 1991; 325: 675-680. Go to original source... Go to PubMed...
  31. Zoli M, Magolotti D, Bianchi G, et al. Efficacy of surveillance program for early detection of hepatocellular carcinoma; Cancer 1996; 78: 977-985. Go to original source...
  32. Sherman M, Peltekian KM, Lee C. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hematology 1995; 22: 432-438. Go to original source...
  33. Collier J, Herman M. Screening for hepatocellular carcinoma. Hematology 1998; 27: 273-278. Go to original source... Go to PubMed...
  34. Bruix J, Sherman M, Llovet JM, et al. EASL. Panel of experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona 2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35(3): 421-430. Go to original source... Go to PubMed...
  35. Takamori R, Wong L, Dang C. Needle-tract implantation from hepatocellular cancer: Is needle biopsy of the liver always necessary? Liver Transpl 2000; 6: 67-72. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.